United States
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 669.91 B |
Jan. 14, 2025 | USD 744.91 | -6.59% |
|
United States |
|
2 |
USD 500.40 B |
Jan. 14, 2025 | USD 543.74 | 0.48% |
|
United States |
|
3 |
USD 348.50 B |
Jan. 14, 2025 | USD 144.75 | 0.19% |
|
United States |
|
4 |
USD 310.22 B |
Jan. 14, 2025 | USD 175.55 | -0.67% |
|
United States |
|
5 |
USD 252.08 B |
Jan. 14, 2025 | USD 99.65 | -1.32% |
|
United States |
|
6 |
USD 213.05 B |
Jan. 14, 2025 | USD 556.99 | 0.27% |
|
United States |
|
7 |
USD 196.03 B |
Jan. 14, 2025 | USD 113.02 | -0.15% |
|
United States |
|
8 |
USD 191.94 B |
Jan. 14, 2025 | USD 538.88 | -0.16% |
|
United States |
|
9 |
USD 171.63 B |
Jan. 14, 2025 | USD 237.62 | -0.94% |
|
United States |
|
10 |
USD 149.67 B |
Jan. 14, 2025 | USD 26.41 | -1.46% |
|
United States |
|
11 |
USD 143.58 B |
Jan. 14, 2025 | USD 267.10 | -1.14% |
|
United States |
|
12 |
USD 140.97 B |
Jan. 14, 2025 | USD 95.65 | 1.10% |
|
United States |
|
13 |
USD 113.41 B |
Jan. 14, 2025 | USD 91.00 | 1.18% |
|
United States |
|
14 |
USD 113.05 B |
Jan. 14, 2025 | USD 55.74 | 0.69% |
|
United States |
|
15 |
USD 106.01 B |
Jan. 14, 2025 | USD 411.66 | -0.41% |
|
United States |
|
16 |
USD 79.28 B |
Jan. 14, 2025 | USD 285.03 | 0.91% |
|
United States |
|
17 |
USD 75.92 B |
Jan. 14, 2025 | USD 690.87 | -3.63% |
|
United States |
|
18 |
USD 75.37 B |
Jan. 14, 2025 | USD 593.73 | 1.48% |
|
United States |
|
19 |
USD 74.18 B |
Jan. 14, 2025 | USD 164.41 | -1.15% |
|
United States |
|
20 |
USD 71.63 B |
Jan. 14, 2025 | USD 87.67 | 0.65% |
|
United States |
|
21 |
USD 68.38 B |
Jan. 14, 2025 | USD 235.80 | -0.17% |
|
United States |
|
22 |
USD 64.90 B |
Jan. 14, 2025 | USD 51.57 | 0.10% |
|
United States |
|
23 |
USD 46.40 B |
Jan. 14, 2025 | USD 240.05 | 1.68% |
|
United States |
|
24 |
USD 41.90 B |
Jan. 14, 2025 | USD 71.04 | -0.07% |
|
United States |
|
25 |
USD 40.96 B |
Jan. 14, 2025 | USD 143.43 | 1.04% |
|
United States |
|
26 |
USD 38.44 B |
Jan. 14, 2025 | USD 84.13 | -1.40% |
|
United States |
|
27 |
USD 35.93 B |
Jan. 14, 2025 | USD 197.96 | -3.26% |
|
United States |
|
28 |
USD 34.28 B |
Jan. 14, 2025 | USD 418.63 | -0.94% |
|
United States |
|
29 |
USD 34.03 B |
Jan. 14, 2025 | USD 282.63 | -1.65% |
|
United States |
|
30 |
USD 33.59 B |
Jan. 14, 2025 | USD 228.83 | -0.62% |
|
United States |
|
31 |
USD 32.01 B |
Jan. 14, 2025 | USD 63.40 | -0.47% |
|
United States |
|
32 |
USD 31.02 B |
Jan. 14, 2025 | USD 240.51 | -6.88% |
|
United States |
|
33 |
USD 30.92 B |
Jan. 14, 2025 | USD 79.17 | -0.84% |
|
United States |
|
34 |
USD 30.02 B |
Jan. 14, 2025 | USD 124.03 | 2.62% |
|
United States |
|
35 |
USD 24.04 B |
Jan. 14, 2025 | USD 404.93 | 1.26% |
|
United States |
|
36 |
USD 23.82 B |
Jan. 14, 2025 | USD 328.96 | -3.13% |
|
United States |
|
37 |
USD 21.88 B |
Jan. 14, 2025 | USD 165.76 | -2.09% |
|
United States |
|
38 |
USD 20.85 B |
Jan. 14, 2025 | USD 143.06 | -4.74% |
|
United States |
|
39 |
USD 20.85 B |
Jan. 14, 2025 | USD 104.71 | -0.74% |
|
United States |
|
40 |
USD 19.61 B |
Jan. 14, 2025 | USD 234.50 | 0.17% |
|
United States |
|
41 |
USD 18.73 B |
Jan. 14, 2025 | USD 267.04 | -0.35% |
|
United States |
|
42 |
USD 17.69 B |
Jan. 14, 2025 | USD 30.03 | 0.13% |
|
United States |
|
43 |
USD 17.07 B |
Jan. 14, 2025 | USD 152.98 | -0.19% |
|
United States |
|
44 |
USD 16.28 B |
Jan. 14, 2025 | USD 364.70 | 0.50% |
|
United States |
|
45 |
USD 15.93 B |
Jan. 14, 2025 | USD 70.20 | -0.13% |
|
United States |
|
46 |
USD 15.63 B |
Jan. 14, 2025 | USD 30.62 | 0.39% |
|
United States |
|
47 |
USD 14.78 B |
Jan. 14, 2025 | USD 21.72 | -1.36% |
|
United States |
|
48 |
USD 14.69 B |
Jan. 14, 2025 | USD 120.73 | -1.61% |
|
United States |
|
49 |
USD 14.38 B |
Jan. 14, 2025 | USD 93.00 | 1.03% |
|
United States |
|
50 |
USD 14.12 B |
Jan. 14, 2025 | USD 139.51 | -2.46% |
|
United States |
The Pharmaceuticals company in United States with the highest Market Capitalization is Eli Lilly and Company (NYSE: LLY) at USD 669.91 B.
The Pharmaceuticals company in United States with the lowest Market Capitalization is 60 Degrees Pharmaceuticals, Inc. (NasdaqCM: SXTP) at USD 2.14 M.
The top 10 Pharmaceuticals companies in United States by Market Capitalization are Eli Lilly and Company, UnitedHealth Group Incorporated, Johnson & Johnson, AbbVie Inc., Merck & Co., Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Intuitive Surgical, Inc., Danaher Corporation and Pfizer Inc..
The bottom 10 Pharmaceuticals companies in United States by Market Capitalization are 60 Degrees Pharmaceuticals, Inc., TransCode Therapeutics, Inc., IMAC Holdings, Inc., iSpecimen Inc., Vaccinex, Inc., Alaunos Therapeutics, Inc., Titan Pharmaceuticals, Inc., Dermata Therapeutics, Inc., Qualigen Therapeutics, Inc. and SCWorx Corp..